Diagnostic value of recombinant tuberculosis allergen and T-SPOT for the diagnosis of tuberculosis in patients with HIV infection
- 22 November 2025
- journal article
- Published by Baltic Medical Education Center in HIV Infection and Immunosuppressive Disorders
- Vol. 17 (3)
Abstract
The aim of the study . To determine the diagnostic significance of recombinant tuberculosis allergen and T-SPOT for the diagnosis of tuberculosis in patients with HIV infection. Materials and methods . In 25 patients (72.0% (18/25) male and 28.0% (7/25) female), who had verified tuberculosis in combination with HIV infection, an immunological study was performed using the recombinant tuberculosis allergen and the TSPOT test. The statistical modeling method was simple logistic regression, calculating the likelihood ratio for intervals of the number of CD4 lymphocytes. Results and discussion . From the CD4 lymphocyte level of 200 cells/ml, the probability curve of a positive test result with the recombinant tuberculosis allergen increases sharply and, starting from the CD4 lymphocyte level of 600 cells/ml (the minimum threshold of a healthy person), takes on a probability close to 1.0 (100%). For the T-SPOT immunological test, the probability curve of a positive test result is more than 50% at a CD4 lymphocyte level of less than 200 cells/mll, approximately 100 cells/mll, and at a CD4 lymphocyte level slightly above 200 cells/ml, the probability curve approaches 1.0 (100%). Conclusion . In diagnostically difficult cases in a patient with HIV infection, it is preferable to use an immunological test with T-SPOT to detect tuberculosis when the number of CD4 lymphocytes decreases to less than 200 cells/ml.Keywords
This publication has 12 references indexed in Scilit:
- Tests for tuberculosis infection: landscape analysisEuropean Respiratory Journal, 2021
- Accuracy of the interferon-γ release assay for the diagnosis of active tuberculosis among HIV-seropositive individuals: a systematic review and meta-analysisBMC Infectious Diseases, 2016
- Development and evaluation of a new interferon-gamma release assay for the diagnosis of tuberculosis infection in HIV-infected individuals in ChinaInfectious Diseases, 2015
- IGRAs – The gateway to T cell based TB diagnosisMethods, 2013
- Interferon-γ Release Assays for the Diagnosis of Tuberculosis and Tuberculosis Infection in HIV-Infected Adults: A Systematic Review and Meta-AnalysisPLOS ONE, 2012
- Interferon-Gamma Release Assays for the Diagnosis of Active Tuberculosis in HIV-Infected Patients: A Systematic Review and Meta-AnalysisPLOS ONE, 2011
- Diagnosis of Active Tuberculosis by Enzyme-Linked Immunospot Assay for Interferon-γ in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infectionBMC Infectious Diseases, 2010
- Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infectionEuropean Respiratory Journal, 2009
- Usefulness of Interferon-Gamma Release Assays in the Diagnosis of Tuberculosis Infection in HIV-Infected Patients in BulgariaBiotechnology & Biotechnological Equipment, 2009